Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-04-03
2007-04-03
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S184000
Reexamination Certificate
active
10363914
ABSTRACT:
Use of a compound of formula (I):whereineach R, which are the same or different, is H or C1–C6alkyl, andX completes a ring which is a substituted triazine having one of the following formulae (II) to (IV):wherein R′ is H or C1–C6alkyl;or an enol tautomer of a compound of formula (I) in which any of the groups R or R′ is hydrogen;in the manufacture of a medicament for use as a protein tyrosine phosphatase (PTP) inhibitor. Formula (I) embraces 2-methylfervenulone, which can be produced by fermentation of a novel microbial strain. Fermentation of the said strain also produces novel precursors to 2-methylfervenulone having utility as prodrugs.
REFERENCES:
patent: 0 407 888 (1991-01-01), None
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
Zhang et al. Expert Opin. Investig. Drugs 12 (2)223-233, 2003.
by Brown et al. Australian Journal of Chemistry, 27(8): 1781-1790, 1974.
Ichiba et al. Journal of Organic Chemistry 43(3): 469-472, 1978.
Taylor et al. Journal of Organic Chemistry 40(16): 2321-2329, 1975.
Taylor and Sowinski, “Structure and Total Synthesis of the Pyrimido . . . ”, Journal of the American Chemical Society 1969, 91, 2143-2144.
Azez and Aleksandrov, “Products of Interaction of Fervenulin-3-One-4-Oxide Witho-Phenylenediamines”, Khimiko-Farmatsevticheskii Zhurnal 34(9):39-41 (2000).
Azev et al, “Synthesis and Some Pharmacological Properties of Isofervenulin Derivatives”, Khimiko-Farmatsevticheskii Zhurnal 14(4):39-44 (1980).
Mel'nik et al, “Synthesis of Glycosidic Derivatives of Reumycin”, Database Biosys 'Online! Biosciences Information Service, Philadelphia, PA, Database Accession No. PREV198375004578, XP002186274 & Bioorganicheskaya Khimiya 7(11):1723-1730 (1981).
Andersen et al, “2-(Oxalylamino)-Benzoic Acid Is a General, Competitive Inhibitor of Protein-tyrosine Phosphatases”, The Journal of Biological Chemistry 275(10):7101-7108 (2000).
Lim Kah Leong
Pallen Catherine J.
Tan Yin Hwee
Wang Haishan
Wang Yue
Balasubramanian Venkataraman
Institute of Molecular and Cell Biology
Nixon & Vanderhye P.C.
LandOfFree
Protein tyrosine phosphatase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein tyrosine phosphatase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein tyrosine phosphatase inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3804851